MEBIAS DISCOVERY INC has a total of 11 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are CALICO LIFE SCIENCES LLC, IMMUNOMET THERAPEUTICS INC and BARUCH S BLUMBERG INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Canada | 1 | |
#5 | Republic of Korea | 1 | |
#6 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Bayoumy Shariff | 11 |
#2 | Tounge Brett A | 10 |
#3 | Kuo Lawrence C | 10 |
#4 | Dax Scott L | 6 |
#5 | Dax Scott | 5 |
#6 | Kuo Lawrence | 1 |
#7 | Tounge Brett | 1 |
Publication | Filing date | Title |
---|---|---|
KR20190104195A | Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamide and methods of making and using the same | |
US2019194178A1 | Substituted ureas and methods of making and using same |